Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02599363
Title A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

breast cancer

Therapies

Paclitaxel + Ribociclib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST